The present disclosure relates to derivatives of bicyclic compounds and their uses in therapy. In particular, the present disclosure relates to derivatives of bicyclic compounds for use in modulating kinase enzymatic activity and accordingly modulating kinase-dependent diseases and conditions such as cancer and in specific embodiments, hepatocellular carcinoma (HCC). The present disclosure also relates to methods of synthesizing these compounds.
                            本公开涉及
双环化合物的衍
生物及其在治疗中的用途。具体来说,本公开涉及
双环化合物的衍
生物,用于调节激酶酶活性,从而调节激酶依赖性疾病和情况,如癌症,特别是肝细胞癌(HCC)。本公开还涉及合成这些化合物的方法。